Actinium Pharmaceuticals
ATNM
ATNM
39 hedge funds and large institutions have $6.63M invested in Actinium Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
19% less capital invested
Capital invested by funds: $8.23M → $6.63M (-$1.6M)
43% less call options, than puts
Call options by funds: $151K | Put options by funds: $265K
Holders
39
Holding in Top 10
–
Calls
$151K
Puts
$265K
Top Buyers
| 1 | +$431K | |
| 2 | +$367K | |
| 3 | +$302K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$159K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$156K |
Top Sellers
| 1 | -$1.47M | |
| 2 | -$716K | |
| 3 | -$493K | |
| 4 |
Bank of New York Mellon
New York
|
-$399K |
| 5 |
Renaissance Technologies
New York
|
-$234K |